ALNYLAM PHARMACEUTICALS, INC. Revenue 2008-2025 | ALNY
What is revenue?
Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
What is ALNYLAM PHARMACEUTICALS, INC.'s current revenue?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual revenue for 2025 was $3.71B, a 65.19% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. revenue for the quarter ending December 31, 2025 was $1.10B.
What was ALNYLAM PHARMACEUTICALS, INC.'s revenue in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual revenue for 2024 was $2.25B, a 22.97% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s revenue in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual revenue for 2023 was $1.83B, a 76.23% increase from 2022.
What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year revenue CAGR?
ALNYLAM PHARMACEUTICALS, INC. revenue grew at a compound annual growth rate (CAGR) of 49.77% from FY2020 to FY2025, going from $492.9M to $3.71B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $3.71B | +65.2% | 10-K |
| FY2024 | $2.25B | +23.0% | 10-K |
| FY2023 | $1.83B | +76.2% | 10-K |
| FY2022 | $1.04B | +22.9% | 10-K |
| FY2021 | $844.3M | +71.3% | 10-K |
| FY2020 | $492.9M | +124.3% | 10-K |
| FY2019 | $219.8M | +7477.6% | 10-K |
| FY2018 | $2.9M | -96.8% | 10-K |
| FY2017 | $89.9M | +90.7% | 10-K |
| FY2016 | $47.2M | -52.9% | 10-K |
| FY2010 | $100.0M | -0.5% | 10-K |
| FY2009 | $100.5M | +4.5% | 10-K |
| FY2008 | $96.2M | - | 10-K |